R.PR
REGISTERED-PRINCIPAL REGISTER
11/01/2022
Voltar para busca
Dado oficial do USPTO
HEPOID
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
HEPOID
ST13
US500000090094968Classe
1, 5, 9, 10, 42, 44
Pedido
90094968
Registro
6610706
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
22
Atualização mais recente
28/10/2022
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 9, 10, 42, 44
Data de depósito
05/08/2020
Data de registro
11/01/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
11/01/2022
Última transação
28/10/2022
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Foreign priority
Código do desenho
4
Tipo de titular
34
Localização do titular
Rennes, FR
Examinador
FOSS,KATHERINE M
Unidade examinadora
N70
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
S. V. (pessoa física)
Representantes
R. Peter Spies DINEFF TRADEMARK LAW LIMITED
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 9Classe 10Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Products made from or derived from hepatic cells for medical research
Classe 5
Pharmaceutical and veterinary preparationspreparations based on hepatic cell modelspreparations in the field of hepatotoxicity and liver diseasepreparations for in vivo and in vitro testsin particular for tests to assess hepatotoxicity/hepatic metabolism and associated mechanisms; hygienic preparations for medicine based on hepatic cell models; chemical preparations for medical or pharmaceutical purposespreparations for testing or treating hepatotoxicity/hepatic metabolism and associated mechanisms or liver diseases; Cellular preparations for medicine; products made from or derived from cells for medical research; Product based on or derived from hepatic cellsfor the performance of toxicity tests for medical purposes
Classe 9
Measuring instruments and apparatus for diagnosisother than for medical usescientific apparatus and instruments for drug discovery screening; data processing equipment and apparatus; recorded software programs for use in drug discovery screening; apparatus computer equipment apparatuscomputer peripheral devices and computersfor medical research and diagnosis and for drug discovery screening; recorded software programs for drug discovery screening; diagnostic devices not for medical usediagnostic apparatus for conducting tests to assess hepatotoxicity/hepatic metabolism and associated mechanisms; devices for non-medical metabolism testing
Classe 10
Surgical apparatus and instruments; medical apparatus and instruments for the diagnostic and treatment of liver disease; medical apparatus and instruments for testing metabolism; medical apparatus and instruments using hepatic cell models for disease diagnosis or treatment; medical apparatus and instruments for in vivo and in vitro tests using hepatic cell models; veterinary apparatus and instruments using hepatic cell models for disease diagnosis or treatment; diagnostic apparatus for medical purposes for conducting test using hepatic cell models; apparatus for use in medical analysisfor measuring liver disease and testing metabolism
Classe 42
Evaluations provided by engineersdrug discovery screening; estimates provided by engineersestimations regarding drug discovery screening; scientific research provided by engineers; technological research in the field of hepatic cells and drug discovery screening provided by engineers; scientific and technological services in the medical and diagnostic fieldproviding medical testing services and information in the field of hepatic cells; scientific research in the field of diagnostics or for medical purposes; electronic storage of medical records; designdevelopmentmaintenance and hosting of databases of medical images and patient data; computer programming in the field of diagnostics or medicine; design and development of medical diagnostic apparatus and equipment; design and development of software for use in medical technology in the field of diagnostics; computer aided diagnostic services in the field of hepatotoxicity and liver diseasecomputer aided diagnostic services in the field of in vivo and in vitro tests; providing scientific information in the medical field; temporary online provision of non-downloadable operating software allowing access to a computer network; software as a service; services featuring software in the field of diagnostics or medicine for processing and displaying data resulting from drug discovery screening; research and development of new products for others; technical project studiesconducting feasibility studies in the field of drug discovery screening; design and development of computer and software in the medical and diagnostic field; computer software consultancy services in the field of diagnostics for medical purposes; medical research; design and developmentinstallationmaintenanceupdating or rental of software; programming for computers; computer technology consultancy; conversion of data and computer programs other than physical conversion; conversion of documents from a physical medium to an electronic medium; scientific research for medical purposes. services relating to cellular products for the medical fieldpreparing in vitro testsin particular tests for assessing hepatotoxicity/hepatic metabolism and associated mechanisms; services relating to cellular products for the medical fielddrug discovery screening; toxicology servicesanalytical services related to cellular products to support for toxicity studies
Classe 44
Medical services
Publicações
Histórico de despachos e eventos da marca no USPTO.
22 publicações encontradas
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
26/10/2021
PUBO
PUBLISHED FOR OPPOSITION
26/10/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/10/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
23/09/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
23/09/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
23/09/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
23/09/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
23/09/2021
DOCK
ASSIGNED TO EXAMINER
27/08/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/07/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/07/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/07/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/07/2021
ALIE
ASSIGNED TO LIE
01/07/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
28/04/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/11/2020
GNRT
NON-FINAL ACTION E-MAILED
05/11/2020
CNRT
NON-FINAL ACTION WRITTEN
05/11/2020
DOCK
ASSIGNED TO EXAMINER
05/11/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/09/2020
NWAP
NEW APPLICATION ENTERED
08/08/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace HEPOID ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.